Showing 11-20 of 56 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| The Effects of Glucagon Antagonism on Insulin Resistance, Ketone Production, and Cardiovascular Risk in Individuals with Type 1 Diabetes | University of California, San Diego | Jeremy Pettus | Improving Lives | 01-June-2021 to 30-November-2026 | $1,233,752.52 |
| Acetazolamide and Tubuloglomerular Feedback in Persons with Type 1 Diabetes: A Clinical Trial | University of California, San Diego | Charles Ginsberg | Improving Lives | 01-November-2022 to 31-October-2026 | $1,356,726.45 |
| Targeting type 1 Diabetes through Polyamines with DFMO | Trustees of Indiana University | Emily Sims | Cures | 01-October-2022 to 30-September-2027 | $3,693,701.00 |
| The Development of 3-β-hydroxybutyrate binding protein based electrochemical micro-sensor and its application for CKM system | The University of North Carolina at Chapel Hill | Koji Sode | Improving Lives | 01-October-2022 to 30-September-2026 | $799,999.96 |
| Project Equity | The Sonia Nabeta Foundation | Vivian Nabeta | Mission | 01-May-2024 to 30-April-2026 | $330,318.56 |
| Project Tuyinza | The Sonia Nabeta Foundation | Vivian Nabeta | Mission | 01-April-2026 to 31-March-2029 | $643,550.00 |
| Quality, Equity & Outcomes Program | The Sonia Nabeta Foundation | Vivian Nabeta | Mission | 01-September-2026 to 31-August-2028 | $1,400,000.00 |
| Triple therapy for T1DM with insulin, semaglutide and dapagliflozin | The Research Foundation of SUNY on behalf of University at Buffalo | Paresh Dandona | Improving Lives | 01-January-2019 to 31-December-2026 | $1,808,522.70 |
| Identification of novel targets to increase human beta cell proliferation | The Regents of the University of California, San Francisco | Gregory Ku | Cures | 01-December-2020 to 31-August-2026 | $975,000.00 |
| Investigation of novel local immunomodulating strategies to enhance islet transplantation for T1D | The Methodist Hospital Research Institute | Alessandro Grattoni | Cures | 01-July-2022 to 30-June-2027 | $962,995.99 |